Lung Cancer, Lung Carcinoma
Conditions
Keywords
Lung Cancer, Lung Carcinoma
Brief summary
The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose computed tomography (radiologic scan) chest scan
Detailed description
The goal of this single-arm pilot research study is to evaluate the feasibility and acceptability of low-dose computed tomography (LDCT) screening for lung cancer among U.S. Black individuals with a history of smoking. LDCT screening is currently the only recommended way to screen for lung cancer among high-risk individuals. However, many Black individuals at high-risk for lunch cancer are currently ineligible for lung cancer screening. Study procedures include screening for eligibility, completion of questionnaires, and a LDCT screening test. Participation in this study is expected to last up to 3 months. It is expected about 900 people will participate in this study.
Interventions
PROCEDURELow-dose Computed Tomography
Per standard care
Sponsors
Massachusetts General Hospital
Agency for Healthcare Research and Quality (AHRQ)
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Self-identified Black individual. * Have a self-reported history of smoking. No restriction will be placed on the number of smoking pack years participants must have nor the number of years former smokers must have quit smoking. * Aged 50-80 years.
Exclusion criteria
* Individuals with a history of lung cancer. * Individuals with symptoms suggestive of lung cancer. We will evaluate whether individuals have symptoms suggestive of lung cancer by administering an online screening questionnaire, which will ask whether they have experienced shortness of breath, whether they become easily winded, and whether they have had a chronic cough within the last 12 weeks that has not improved. Individuals who select that they have any one of these symptoms will be advised to follow up with their primary doctor and will not be eligible to participate in the study. * Individuals with pneumonia or acute respiratory infection within 12 weeks prior to enrollment that was treated with antibiotics.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of Enrolled Participants | At enrollment | Primary endpoint is feasibility. Feasibility is defined as the percentage of individuals invited to participate in the trial who enroll. |
| Proportion of Participants with Positive Low-dose Computed Tomography Test | At 3 months | The percentage of participants who have a positive low-dose computed tomography test will be evaluated. This percentage will be compared to the Black individuals randomized to the low-dose computed tomography screening arm in the National Lung Screening Trial (historical control). |
| Proportion of Participants Diagnosed with Invasive Lung Cancer | At 6 months | The proportion of participants with a lung cancer diagnosis post-low-dose computed tomography screening test will be compared to Black individuals randomized to the LDCT screening arm in the National Lung Screening Trial (historical control). |
| Distribution of Lung Imaging Reporting and Data System (Lung-RADS) Scores | At 3 months | The distribution of Lung-RADS scores among participants will be evaluated and compared to the distribution of Lung-RADS scores among Black individuals randomized to the LDCT screening arm in the National Lung Screening Trial (historical control). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of Participants Who Undergo Invasive Diagnostic Procedures | At 6 months | The proportion of participants who undergo invasive diagnostic procedures will be evaluated and compared to the proportion of Black individuals randomized to the LDCT screening arm in the National Lung Screening Trial (historical control) who underwent invasive diagnostic procedures. |
| Proportion of Participants Who Have a Complication Resulting from an Invasive Diagnostic Procedure Performed for a Positive Low-dose Computed Tomography Scan | At 6 months | The proportion of participants who have a complication resulting from an invasive diagnostic procedure performed for a positive low-dose computed tomography scan will be evaluated. This proportion will be compared to the proportion of Black individuals randomized to the low-dose computed tomography screening arm in the National Lung Screening Trial (historical control) who had a complication resulting from an invasive diagnostic procedure performed for a positive low-dose computed tomography scan. |
Countries
United States
Contacts
CONTACTChi Fu Jeffrey Yang, MD
PRINCIPAL_INVESTIGATORChi Fu Jeffrey Yang, MD
Massachusetts General Hospital
Outcome results
None listed